文献速递呼吸危重症与机械通气呼吸道感染

免疫功能受损患者最终需有创机械通气后的生存分析:个体患者数据汇总分析

Survival in Immunocompromised Patients Ultimately Requiring Invasive Mechanical Ventilation: A Pooled Individual Patient Data Analysis.
PubMed 文献 · Am J Respir Crit Care Med · 2021-01-01

该研究基于2008至2018年发表的24项研究(含3项对照试验和21项队列)的个体患者数据,纳入11,087例需有创机械通气的免疫功能受损急性呼吸衰竭成人患者。结果显示粗死亡率为53.2%,校正后生存率随时间改善(1995至2017年,每年住院死亡OR为0.96 [0.95-0.97]);ICU入科至插管每延迟一天死亡风险更高(OR 1.38 [1.26-1.52],P<0.001),早期插管与较低死亡相关(OR 0.83 [0.72-0.96])。

要点

  • 免疫功能受损患者有创机械通气粗死亡率达53.2%。
  • 1995至2017年校正后生存率逐年改善,住院死亡OR为0.96。
  • ICU入科至插管每延迟一天,死亡OR为1.38,早期插管死亡OR为0.83。

核心结论

  • 免疫功能受损的有创机械通气患者生存率随时间改善。
  • ICU入科至插管的时间是死亡的强预测因素,提示初始氧合策略失败后延迟插管可能有害。

研究设计与样本

  • 系统综述与个体患者数据荟萃分析,纳入24项研究(3项对照试验和21项队列),共11,087例患者。
  • 研究对象为需有创机械通气的免疫功能受损急性呼吸衰竭成人患者,检索2008至2018年PubMed、Web of Science和Cochrane Central的英文文献。

主要发现

  • 7,736例(74%)在ICU入科24小时内插管(早期插管)。
  • 粗死亡率为53.2%。
  • 校正后生存率随时间改善:1995至2017年每年住院死亡OR为0.96(0.95-0.97)。
  • ICU入科至插管每延迟一天,死亡OR为1.38(1.26-1.52),P<0.001。
  • 早期插管与较低死亡显著相关(OR 0.83 [0.72-0.96]),且不受初始氧合策略影响;倾向评分分析后延迟插管匹配OR为1.56(1.44-1.70)。

临床怎么用

  • 对免疫功能受损的急性呼吸衰竭患者,应密切监测无创氧合策略效果,避免延迟插管。
  • ICU入科至插管时间是死亡的重要预测因素,早期插管可能改善生存。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Rationale: Acute respiratory failure (ARF) is associated with high mortality in immunocompromised patients, particularly when invasive mechanical ventilation is needed. Therefore, noninvasive oxygenation/ventilation strategies have been developed to avoid intubation, with uncertain impact on mortality, especially when intubation is delayed. Objectives: We sought to report trends of survival over time in immunocompromised patients receiving invasive mechanical ventilation. The impact of delayed intubation after failure of noninvasive strategies was also assessed. Methods: Systematic review and meta-analysis using individual patient data of studies that focused on immunocompromised adult patients with ARF requiring invasive mechanical ventilation. Studies published in English were identified through PubMed, Web of Science, and Cochrane Central (2008-2018). Individual patient data were requested from corresponding authors for all identified studies. We used mixed-effect models to estimate the effect of delayed intubation on hospital mortality and described mortality rates over time. Measurements and Main Results: A total of 11,087 patients were included (24 studies, three controlled trials, and 21 cohorts), of whom 7,736 (74%) were intubated within 24 hours of ICU admission (early intubation). The crude mortality rate was 53.2%. Adjusted survivals improved over time (from 1995 to 2017, odds ratio [OR] for hospital mortality per year, 0.96 [0.95-0.97]). For each elapsed day between ICU admission and intubation, mortality was higher (OR, 1.38 [1.26-1.52]; P < 0.001). Early intubation was significantly associated with lower mortality (OR, 0.83 [0.72-0.96]), regardless of initial oxygenation strategy. These results persisted after propensity score analysis (matched OR associated with delayed intubation, 1.56 [1.44-1.70]). Conclusions: In immunocompromised intubated patients, survival has improved over time. Time between ICU admission and intubation is a strong predictor of mortality, suggesting a detrimental effect of late initial oxygenation failure.

来源:Am J Respir Crit Care Med,查看原文。版权归原作者所有。

引用

  1. Dumas G, Lemiale V, Rathi N, et al. Survival in Immunocompromised Patients Ultimately Requiring Invasive Mechanical Ventilation: A Pooled Individual Patient Data Analysis. Am J Respir Crit Care Med. 2021. PMID: 33751920. doi:10.1164/rccm.202009-3575OC

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。